Skip to main content

Javier Villacieros Álvarez

I am a neurologist and I am currently doing my PhD in basic research on MOG antibodies associated disease (MOGAD).

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Investigador/a predoctoral
Multiple Sclerosis Centre of Catalonia

Javier Villacieros Álvarez

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Investigador/a predoctoral
Multiple Sclerosis Centre of Catalonia

I am a neurologist and I am currently doing my PhD in basic research on MOG antibodies associated disease (MOGAD).

I completed my training period in Neurology at the Hospital Universitario de La Princesa (Madrid). Subsequently, I worked as a Specialist Physician in Hospital Rey Juan Carlos (Madrid) from September 2019 to January 2022, with care activity focused mainly on neuroimmunology. At the moment I work as a predoctoral researcher at the Center d 'Sclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Hospital (Barcelona), after obtaining a PFIS grant from the Carlos III Health Institute. The research project is focused on MOG antibodies associated disease (MOGAD), studying biomarkers in MOGAD with different laboratory techniques (cell-based assay, immunocytochemistry, flow cytometry, SIMOA, etc), as well as the analysis of different clinical and radiological characteristics, and evolution and prognosis of patients with a first demyelinating event suggestive of multiple sclerosis based on the presence or absence of MOG antibodies. I spent a stay at the National Hospital for Neurology and Neurosurgery, Queen Square, London, learning about different laboratory techniques (ELISA, Cell based assays, immunoblot, immunohistochemistry, immunoprecipitation, etc), and actively collaborating in the experiments of different groups. To date I am part of 8 publications of scientific articles, being first or second author in 5 of them. In addition, I have made more than 10 presentations at conferences as first author.

Projects

SGR-Cat 2021: Neuroimmunologia Clínica

IP: Xavier Montalban Gairín
Collaborators: Ana Isabel Guerrero Perez, Carlos Nos Llopis, Sunny Malhotra Sareen, José Ant. Graells Salvador, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Andrea Serrano Mascarós, Margarida Capell Maymo, Samuel Sánchez Pous, Elisenda Anglada Clofent, Montserrat Aroca Alsina, Silvia Soler García, Sergio Cabello, Carmen Tur Gomez, Gabriel Ig Camiña Rodríguez, Herena Eixarch Ahufinger, Carme Santoyo Medina, Oriol Nualart Mundo, Mar Tintore Subirana, M Jesus Arevalo Navines, Edwin Roger Meza Murillo, Augusto Cesar Sao Aviles, Miguel Angel Robles Sanchez, Dunia Muñoz Valdivielso, Carmen Espejo Ruiz, Marta Rodríguez Barranco, Gaizka Loyola Sanmillan, Mireia Resina Salles, Angela Vidal Jordana, Lucía Gutiérrez Ruiz, Ana Zabalza de Torres, Sergio Vergara Ruiz, Javier Villacieros Álvarez, Rafael Garcia Merida, Maria Arantza Dema Etxezarreta, Luciana Midaglia Fernandez, Alvaro Cobo Calvo, Neus Mongay Ochoa, Joaquin Castillo Justribo, Milagros Fraga Pereira, Breogan Rodriguez Acevedo, SGR-Cat 2021: Neuroimmunologia Clínica, Mireia Castillo Juarez, Rucsanda Pinteac, Nicolás Miguel Fissolo
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 00782
Duration: 01/01/2022 - 30/06/2025

Deciphering clinical features and pathogenesis of myelin oligodendrocyte glycoprotein (MOG) antibodies in adult patients with a first demyelinating syndrome

IP: Alvaro Cobo Calvo
Collaborators: Javier Villacieros Álvarez, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 119567
Reference: FI21/00282
Duration: 01/01/2022 - 31/12/2025

Related news

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.

The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.

Related professionals

Maria Margaret Mercadal Hally

Maria Margaret Mercadal Hally

Research technician
Hepato-bilio-pancreatic surgery (HBP) and liver transplantation
Read more
Concepció Jacobs Cachá

Concepció Jacobs Cachá

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Ana Torcida Alonso

Ana Torcida Alonso

Research technician
Stroke research
Read more
Victor Franco Puntes

Victor Franco Puntes

Head of group
Pharmacokinetic Nanoparticles
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.